EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of N6-methyladenosine in the progression, treatment regulation, and prognosis prediction of lung cancer

Shufan Liang, Jun Shao, Jingwei Li, Xingting Liu, Liuqing Yang, Weimin Li, Chengdi Wang

Holistic Integrative Oncology · 04.06.2026 · 5 (1)

DOI: 10.1007/s44178-026-00259-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Holistic Integrative Oncology, online erschienen am 04.06.2026. Verfasst von Shufan Liang und 6 weiteren Autor:innen. Die Arbeit nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer, the leading cause of tumor-related mortality worldwide, poses a severe threat to public hygiene. Advances in precise personalized treatment strategies, such as targeted therapy and immunotherapy, present promising prospects for lung cancer cure. Nonetheless, owing to the undefined underlying mechanism of carcinogenesis and unpredictable treatment efficacy, the overall management of lung cancer remains a great concern. N 6 -methyladenosine (m 6 A), identified as pervasive and conserved eukaryotic transcriptional epigenetic modification, has been revealed to exert a noneligible influence on many biological processes through regulation of ribonucleic acid (RNA) splicing, degradation, and translation. Furthermore, intensive investigations suggest that the m 6 A modifications and subsequent alterations to transcripts may be involved in the occurrence and progression of various tumors. In this review, we provide the newest insight into the role of m 6 A modification in lung cancer, focusing on its impact on progression, treatment regulation, and prognosis prediction, which may guide future research based on m 6 A to discover more novel therapeutic targets to combat this fatal disease.

Zitieren

APA

Liang, S., Shao, J., Li, J., Liu, X., Yang, L., Li, W., & Wang, C. (2026). Role of N6-methyladenosine in the progression, treatment regulation, and prognosis prediction of lung cancer. Holistic Integrative Oncology, 5(1). https://doi.org/10.1007/s44178-026-00259-8

Vancouver

Liang S, Shao J, Li J, Liu X, Yang L, Li W, et al. Role of N6-methyladenosine in the progression, treatment regulation, and prognosis prediction of lung cancer. Holistic Integrative Oncology. 2026;5(1). doi:10.1007/s44178-026-00259-8

BibTeX
@article{Liang2026,
  author = {Liang, Shufan and Shao, Jun and Li, Jingwei and Liu, Xingting and Yang, Liuqing and Li, Weimin and Wang, Chengdi},
  title = {Role of N6-methyladenosine in the progression, treatment regulation, and prognosis prediction of lung cancer},
  journal = {Holistic Integrative Oncology},
  year = {2026},
  volume = {5},
  number = {1},
  doi = {10.1007/s44178-026-00259-8}
}
Kostenlos starten →